Invention Grant
- Patent Title: Intranasal stimulation for treatment of meibomian gland disease and blepharitis
-
Application No.: US15584956Application Date: 2017-05-02
-
Publication No.: US10918864B2Publication Date: 2021-02-16
- Inventor: Manfred Franke , Diane Michelle Senchyna , Daniel N. Hamilton
- Applicant: Oculeve, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Oculeve, Inc.
- Current Assignee: Oculeve, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61N1/00
- IPC: A61N1/00 ; A61N1/36 ; A61N1/05

Abstract:
Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.
Public/Granted literature
- US20170312521A1 INTRANASAL STIMULATION FOR TREATMENT OF MEIBOMIAN GLAND DISEASE AND BLEPHARITIS Public/Granted day:2017-11-02
Information query